~~<i id='145E714F2D'><strike id='145E714F2D'><tt id='145E714F2D'><pre id='145E714F2D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

hotspot

author：comprehensive 2025-09-27 10:00:50 - browse：6

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Close Medicare's dangerous gaps in addiction treatment coverage

focus

leisure time

focus

entertainment

Rakus,aSumatranorangutan,usedthejuiceandleavesofamedicinalplanttotreatawoundonhisface.CourtesyArmasW

WSS

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

More tobacco lobbyists active in statehouses

H5N1 bird flu virus started spreading in cows in Texas in December

More tobacco lobbyists active in statehouses

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Bird flu surveillance in wastewater gets boost from consortium

Wikipedia

hotspot

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

H5N1 virus can be tracked in retail milk, scientists say

Supreme Court strikes down use of affirmative action

Exact Sciences stock tumbles despite strong cancer detection sales

Medicare proposal to cover medical devices draws a mixed reaction

For longer

Medicare proposal to cover medical devices draws a mixed reaction

ASCO eve: Let’s set the table for this year's meeting

Jerome Adams on the need for new antivirals for Covid

H5N1 virus can be tracked in retail milk, scientists say

leisure time

Reports of telehealth's death have been greatly exaggerated

Bird flu surveillance in wastewater gets boost from consortium

H5N1 virus can be tracked in retail milk, scientists say

Key Senate committee drafts bipartisan bill to stem drug shortages

Orangutan used medicinal plant to treat wound, first time ever seen

Digital health: a case of mistaken identity

focus

focus

focus

entertainment